Investing Profile

Galym Imanbayev

InvestorVC
Partner at Lightspeed Venture Partners
Photo of Galym Imanbayev, Partner at Lightspeed Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$3.0M - $20.0M
$15.0M
10
CompanyStageDateRound SizeTotal Raised
Assort Health
Series BAug 2025$76M
$100M
Co-investors: Kristina Shen (Andreessen Horowitz), Bill Trenchard (First Round Capital), Matt Humphrey (Quiet Capital)
Frontera Health
SeedFeb 2025$32M
$32M
Co-investors: Bilal Zuberi (Lux Capital)
Abridge
Series DFeb 2025$250M
Series CFeb 2024$150M
$760M
Co-investors: Somesh Dash (IVP), William Reed (Spark Capital), Sebastian Duesterhoeft (Lightspeed Venture Partners), Andy Weissman (Union Square Ventures), David George (Andreessen Horowitz), Jamie Goldstein (Pillar VC), Vijay Patel (CVS Health), Faraz Rahman (CVS Health), Esther Dyson, Yoshua Bengio, Elad Gil
Aledade
Series FJun 2023$260M
$550M
Co-investors: Craig Sherman (Meritech Capital Partners), Bob Kocher (Venrock)
Fathom
Series BNov 2022$46M
$60M
Co-investors: Justin Kan (Goat Capital), Josh Buckley (Buckley Ventures), Matt Ocko (DCVC (Data Collective)), Jason Calacanis (LAUNCH), Simon Chan (FirstHand Alliance), Martin Alexander Gershon (Endeavor Venture Funds), Alex MacCaw (Earl Grey Capital), Mark McLaughlin (Alkeon Capital), David Murray-Hundley (Pario Ventures), Jinal Jhaveri (Runa Capital), Aaron Rankin (Sprout Social, Inc.), Mujtaba Wani (GSV Ventures), Milad Alucozai (BoxOne Ventures), Shaan Puri (Shaan's All Access Fund), Jim Scheinman (Maven Ventures), Mikhail Seregine, Oleg Rogynskyy, Daniel Kan, Emmett Shear, Kyle Vogt, Ted Serbinski, Vikas Gupta, Jay Jamison, Immad Akhund, Vishal Rao, Bill Tai, Adam Michalski, Aaron King, Jason Hunt, Viral Bajaria, Chris Fanini
Ancora Biotech LLC
Series AJun 2022$60M
$60M
Kirilys Therapeutics
SeedMar 2022
Wheel
Series CJan 2022$150M
Series BMay 2021$50M
$220M
Co-investors: Kristin Baker Spohn (CRV), Jay Chen (Tiger Global Management), Mark Suster (Upfront Ventures), Tony Fadell (Future Shape), Roger Chen (Silverton Partners), Morgan Flager (Silverton Partners), Jordan Nof (Tusk Venture Partners), Ling Wong (Highbury Group)